CD274 and cancer: Meanwhile, Vanderwalde et al. performed MSI assays using NGS methods to highlight the relationship between MSI, TMB, and PD-L1 using over 11,000 patients across cancer types and suggested MSI as a marker with TMB and PD-L1 expression to determine the use of ICIs [125].